However, more recent studies have implicated a more robust pharmacodynamic association between a diagnosis of ADHD and serotonin transporter, dopamine transporter, dopamine receptor, COMT and other pertinent genes (McGough et al., 2009; Joensen et al., 2017). This evidence concerns the gene SLC6A3 and attention deficit-hyperactivity disorder.